• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Tool may help accurately predict 30-day mortality for emergency department patients with acute heart failure

byEvelyn NguyenandDeepti Shroff Karhade
October 4, 2017
in Cardiology, Chronic Disease, Emergency, Nephrology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Based on 13 independent risk factors that are available at most emergency department (ED) admissions, the MEESSI-AHF (Multiple Estimation of risk based on the Emergency department Spanish Score In patients with Acute Heart Failure) score was able to accurately predict 30-day mortality in ED patients with AHF, particularly those at very high or low risk.

2. Using this tool may especially be of use in identifying ED patients with AHF at very high or low risk of 30-day mortality, which can be important for treatment management decisions.

Evidence Rating Level: 2 (Good)       

Study Rundown: Every year in the United States and Europe, over 1 million hospitalizations result from AHF. About 90% of these patients go to the ED. Decisions made in the ED are crucial, but no stratification of patients by risk occurs during this process. Although there are AHF risk scores available, a more dependable tool is necessary. This prospective cohort study sought to predict mortality data based on information available from ED admission. Using 13 independent risk factors found in the derivation cohort, researchers combined them into an overall score named the MEESSI-AHF score. The outcomes were tested again with a validation cohort. The tool was shown to be able to accurately predict 30-day mortality risk for these patients. ED physicians may take this tool (which includes an online calculator for ease of use) into consideration to assist with clinical decisions. Further studies can help reveal whether or not this tool improves clinical choices and patient outcomes.

A strength of the study is that the 13 predictors identified are normally available in worldwide routine clinical practice. Limitations of the study include use of EDs in a single country, non-random ED selection, patients with missing data, and subjectivity of some risk factor measurements.

Click to read the study in Annals of Internal Medicine

RELATED REPORTS

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart failure with preserved or mildly reduced ejection fraction

Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure

Relevant Reading: Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model

In-Depth [prospective cohort]: The Epidemiology of Acute Heart Failure in Emergency Departments (EAHFE) registry collects information on patients with a final AHF diagnosis at 34 Spanish EDs. The derivation cohort was comprised of 4867 AHF patients who were admitted to the ED during 2009 to 2011. Using a logistic regression model, researchers identified 13 independent predictors of mortality: Barthel index score at admission, systolic blood pressure, age, N-terminal pro–B-type natriuretic peptide level, potassium level, positive troponin level, New York Heart Association class IV disease at admission, respiratory rate, low-output symptoms, oxygen saturation, episode associated with acute coronary syndrome, hypertrophy on electrocardiography, and creatine level. The validation cohort included 3229 AHF patients who were admitted to the ED during 2014. The MEESSI-AHF score was able to predict 30-day mortality with good discrimination and calibration, especially in patients at very high (10% of patients, ~45% risk) or low risk (40% of patients, <2% risk) of death in 30 days. Identifying these groups may be important in treatment management.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: congestive heart failurehospital admission
Previous Post

Adding postpolypectomy surveillance to fecal immunochemical testing is not cost-effective

Next Post

The EVS: Vitrectomy results in better visual outcomes for light-perception patients [Classics Series]

RelatedReports

Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

July 4, 2025
Quick Take: Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm
Cardiology

Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart failure with preserved or mildly reduced ejection fraction

October 18, 2024
Pharma

Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure

October 3, 2024
Parental conceptions of weight are becoming increasingly inaccurate
Cardiology

Semaglutide reduces heart failure events in patients with preserved ejection fraction

September 24, 2024
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The EVS: Vitrectomy results in better visual outcomes for light-perception patients [Classics Series]

Vaccination rates unchanged after live attenuated influenza vaccine recommendation removal

Vaccination rates unchanged after live attenuated influenza vaccine recommendation removal

Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma

2 Minute Medicine Rewind October 2, 2017

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard
  • AAV gene therapy shows durable benefit in hemophilia B
  • Type 2 diabetes and abnormal amyloid concentrations are associated with accelerated brain atrophy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.